The Budget Got Signed. The Science Money Got Handcuffed.
United States – February 28, 2026 – Congress funded NIH and NSF, but OMB is slow-walking cash to enforce politics by spreadsheet and silence labs.
The fluorescent hum gets louder when the money stops moving. You can feel it in the missing award notices, the stalled hiring, the procurement that turns into a waiting room with no clock. The research machine does not explode. It just starts to wheeze.
OMB slows release of congress-approved science funding for NIH, NSF, NASA
On February 27, 2026, Nature reported that the White House Office of Management and Budget has been slow-walking the release of science funds Congress appropriated and President Donald Trump signed into law on February 3, 2026. According to the report, NIH has not received approval to spend any of the research funding allocated in the 2026 bill. NSF received its authorization last week. NASA’s funding was authorized, but with an unusual restriction on ten specific science programs pending more details.
This is not a nerdy process story. It is power. A hand on the faucet while everyone else gets blamed for the drought.
Translation: “Apportionment” is paperwork with teeth
Translation: “Apportionment” sounds like accounting because it is. In practice it is the gate between Congress saying “spend this” and agencies being able to spend it. If OMB delays, it is not just a late check. It is delayed experiments, delayed clinical trials, delayed equipment contracts, and delayed careers.
Nature also describes a rule tweak. After a full-year budget is signed, agencies typically receive a rolling 30-day portion while OMB approves spending plans. For fiscal year 2026, OMB revised Circular A-11 so those 30-day portions cover only essential expenses like salaries, not the research awards themselves. The lights stay on. The paychecks clear. The actual point of the agencies gets shoved into limbo.
Here is the mechanism: Make the slowdown look like “efficiency”
Here is the mechanism: throttle the flow, then point at the slowdown as evidence the system is “wasteful” or “broken.” Manufacture the backlog, then cite the backlog to justify “reform.” It is political control by memo and plausible deniability by delay.
In Nature’s reporting, NIH has been operating on leftover funds, and award activity has fallen sharply compared with prior years. NSF’s award pace is also dramatically down. Meanwhile, OMB does not answer questions. That is also part of the mechanism.
Follow the money: Who benefits from strangling public science
Follow the money: when public research slows, private gatekeepers get stronger. Universities lean harder on industry partnerships. Labs chase corporate-sponsored work with corporate veto points. Trainees become cheaper labor in a more desperate market. Venture-backed firms gain leverage over talent and intellectual property that used to grow in publicly funded ecosystems.
Nature reports that OMB Director Russell Vought has argued OMB’s control over funding is an indispensable tool to ensure agencies adhere to White House priorities, and that OMB can provide less than what Congress appropriated. That is not neutral budgeting. That is an assertion of supremacy over the power of the purse, with scientists as collateral.
The quiet part: you do not have to outlaw research to discipline it. You just have to make it unreliable.
Scientific integrity is also whether scientists can work
Scientific integrity is not only about falsified charts. It is whether a country can run a research enterprise insulated from partisan choke points. If a budget can be signed on February 3, 2026 and the research dollars can still be effectively locked up weeks later, that is a system-level integrity failure, not a clerical mishap.
Nature reports that top Democratic appropriators including Rep. Rosa DeLauro and Sen. Patty Murray demanded OMB release funds as required by law, while Republican chairs did not respond to queries. Silence is not passive here. It is permission.
Mic drop: Congress needs subpoenas, not stern letters. Inspectors general need audits of apportionment bottlenecks. Courts need to hear challenges if executive impoundment is being dressed up as “process.” And universities and scientific societies need to organize publicly around a basic premise: a signed law is supposed to function like a signed law.